Abstract Abyssomicin C is a complex polyketide-type antibiotic and the first natural inhibitor of the paminobenzoate biosynthesis produced by the marine Verrucosispora strain AB-18-032. We have now isolated three novel naturally produced abyssomicins, among them the even more active atrop-abyssomicin C. The chemical structures were elucidated by mass spectrometry and NMR spectroscopy.
raphy and size-exclusion chromatography, followed by preparative reversed-phase HPLC as described previously [2] , but using acid free solvents.
In submerged cultures of Verrucosispora AB-18-032 4 is the major product reaching maximal yields of 60 mg/litre, followed by 2 with 8.0 mg/litre, whereas 1, 3, 5 and 6 are minor congeners. Nomenclature of the new compounds is based on the historic course of our abyssomicin research. For structure elucidation, 4ϳ6 were analyzed by mass spectrometry and by 1D and 2D NMR spectroscopy ( Table  1 ). The high-resolution ESI-FTICR mass spectra of 4ϳ6 showed masses of m/z 347.14892 Da (4) NMR experiments were measured on a DRX500 NMR spectrometer (Bruker, Karlsruhe, Germany) equipped with a 5 mm diameter broad band inverse probehead with z gradients. Spectra were recorded in and referenced to [D 4 ]methanol (3.30 ppm; 49.0 ppm). 2D COSY, NOESY, HMQC and HMBC experiments were measured with standard Bruker parameters (XWinNMR 3.2). LC-MS experiments were performed on a 2000 Q Trap mass spectrometer (Applied Biosystems/MDS Sciex) coupled to an Agilent 1100 HPLC system (Agilent, Waldbronn, Germany). FTICR-ESI mass spectra were recorded on an APEX II FTICR mass spectrometer (4.7 T, BrukerDaltonics, Bremen, Germany). Spectra were calibrated using PEG 400 as an internal standard.
From 1D and 2D NMR spectra, 4 was identified as atropabyssomicin C [6] . 5 has the same molecular formula as 2. 2D NMR data from COSY, TOCSY, HMQC, and HMBC experiments were found to be similar to 2, except for chemical shift differences in the western molecule part adjacent to the oxabicyclooctane system (C (7)ϳC (9)). The connectivity of C(7) through C(10) was established based on HMBC correlations. H-C(8) couples to C(7), C(9), and C(10), and H-C(10) couples to C(7), C(8), C(9) in addition Table 1 1 H-and 13 C-NMR shifts of atrop-abyssomicin C, abyssomicins B, G, and to correlations to C(11), C(14), C(15), and C(16). The most striking difference in chemical shifts of the 13 C-NMR spectrum is 116 ppm versus 211 ppm for C(7) of 2 and 5, respectively. This leads to the conclusion that, as in 1 and 3, C(7) is the carbonyl of a ketone. Chemical shifts of C(8) with 3.77 ppm and 3.48 ppm in 1 H and 46.8 ppm in 13 C, C(9) with 13 C shift of 151.7 ppm, and C(10) with 1 H shift of 3.73 ppm and 13 C shift of 47.4 ppm combined with the molecular formula derived from HR-ESI-FTICR-MS are in good agreement with the proposed structure, bearing an oxime at C(9) (Fig. 1) . 5 is stable under room temperature and does not spontaneously rearrange to 2.
6 has the same molecular formula as 3. However, 1D and 2D spectra are more similar to 1, except for major chemical shift deviations for C(8) and C(9). The connectivity of C(7) through C(10) was established based on COSY correlations of H-C(9) to H-C(8) and H-C(10) and HMBC correlations. HMBC correlations are found between H-C(8) and C(6), C(7), C(9), and C(10), between H-C(9) and C(7), C(8), C(10), and C(11), and between H-C(10) and C(8), C(9), C(11), C(14), C(15), and C(16). The assignment of chemical shifts shows that in 1, C(8) and C(9) are connected via a double bond, whereas in 6, C(8) and C(9) are reduced to methylene units (Fig. 1 ). 5 and 6 are novel members of the abyssomicin family and were named abyssomicin G and H (Fig. 1) . Antibacterial tests performed as described in [2] for 5 (MIC Ͼ1 mM) and 6 (MIC Ͼ1 mM) showed no antibacterial activities.
Remarkably, 4, previously described only by synthetic chemists, is also naturally produced by Verrucosispora AB-18-032, as assumed previously by Nicolaou and Harrison [7] . In fact in our fermentations 4 appeared as the main product. Reconsideration of experimental data from previous cultivations of Verrucosispora AB-18-032 which led to the discovery of 1 indeed confirmed the presence of 4. However, 4 depleted during previous purifications or was converted to 1 by use of acidic HPLC solvents. The extremely high similarity of both compounds with regard to retention time and UV spectra obscured an earlier observation of this loss. The antibacterial assay performed by our groups confirmed a stronger inhibitory effect for 4 compared to 1 as found by Nicolaou and Harrison [6] describing a 1.5 fold lowered MIC value for 4 against MRSA. Abyssomicins G (5), which is a putative precursor of 2 displays no antibiotic activity and thus confirms the crucial role of an intact Michael-acceptor system located at C(7)ϳC (9) . The biosynthesis of 5 might occur via addition of ammonia and subsequent N-oxidation by a monooxygenase. N-oxidized natural products have been found to be often biosynthesized via a hydroxylamine intermediate catalyzed by flavin monooxygenases [8] . The postulated oxime formation has been described by the Townsend group for nocardicin A and was found to be mediated by a cytochrome P450 enzyme [9] . More strikingly, in 6 with MIC values of Ͼ1 mM the Michael system C(7)ϳC (9) is destroyed by reduction of the alkene at C(8)ϳC (9) to the corresponding alkane. This underscores the likely action of 1 and 4 as antibacterials with Michael-acceptor properties. Furthermore, this assumption is strongly supported by MIC-assays of Nicolaou and Harrison [7] performed on 1 analogs showing that reduction of the ketone at C(7) to the corresponding hydroxy group leads to complete loss of antibacterial activity. 3 and 6 are products of a formal hydrogen addition. As the experiments from Nicolaou and Harrison show, the incubation of an NADH analogue with 4 lead to the formation of 3 [7] . Incubations of 1 and 4 in our lab with NaBH 4 in THF lead to the formation of both 3 and 6. For the synthesis of 6 a Michael addition of a hydrogen equivalent or the action of an enoylreductase of a polyketide synthase seems possible. Current experiments by our groups directed to the elucidation of the biosynthetic assembly of abyssomicins will further address these questions. 
